Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -66.559% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCOC(=O)Cn1c(-c2ccccc2)ccc(C#N)c1=O
b.) CC(=O)N1CCN(c2ccccc2NC(=O)c2cc(Br)ccc2Cl)CC1
c.) COc1cccc(Cn2c(NCc3ccco3)nc3c2c(=O)n(C)c(=O)n3C)c1
Answer: b. CC(=O)N1CCN(c2ccccc2NC(=O)c2cc(Br)ccc2Cl)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N1CCN(c2ccccc2NC(=O)c2cc(Br)ccc2Cl)CC1
CC(=O)N1CCN(c2ccccc2NC(=O)c2cc(Br)ccc2Cl)CC1
5-bromo-N-[2-(4-acetyl-1,4-diazinan-1-yl)phenyl]-2-chlorobenzamide